Skip to main content
Erschienen in: Journal of Thrombosis and Thrombolysis 3/2017

21.08.2017

Efficacy of standard dose unfractionated heparin for venous thromboembolism prophylaxis in morbidly obese and non-morbidly obese critically Ill patients

verfasst von: Young R. Lee, Delilah D. Blanco

Erschienen in: Journal of Thrombosis and Thrombolysis | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

To determine the efficacy of standard dose unfractionated heparin (UFH) for venous thromboembolism (VTE) prophylaxis in critically ill morbidly obese patients. Retrospective single-center observational cohort study in a single tertiary teaching hospital intensive care units (ICUs) in Multiparameter Intelligent Monitoring in Intensive Care II Clinical Database. Patients 18 years or older, admitted to the ICU, and received either UFH 5000 units subcutaneously twice daily or UFH 5000 units three times daily for VTE prophylaxis between 2001 and 2008 were included. Total 243 patients in the BMI ≥ 40 kg/m2 group and 2813 patients in the BMI < 40 kg/m2 group were identified. There was no difference in VTE incidence between the two groups. However, a strong linear association was found showing as BMI increased so did the rate of VTE incidence. Morbidly obese patients had longer hospital (17 vs. 14 days, P = 0.016) and ICU length of stay (10 vs. 8 days, P = 0.007). After controlling Padua score, logistic regression analysis revealed the odds of VTE increased by a factor of 1.026 for each one-unit increase in BMI. Additionally, having a BMI ≥ 40 kg/m2 was associated with a greater likelihood of VTE incidence in males (OR 3.92) but not in females. In patients treated with standard dose UFH, morbid obesity does not increase VTE risk overall. However, BMI has a strong linear relationship with VTE incidence and morbid obesity is more likely associated with greater hospital and ICU length of stay.
Literatur
1.
Zurück zum Zitat Cook D, Crowther M, Meade M et al (2005) Deep venous thrombosis in medical-surgical critically ill patients: prevalence, incidence, and risk factors. Crit Care Med 33(7):1565–1571CrossRefPubMed Cook D, Crowther M, Meade M et al (2005) Deep venous thrombosis in medical-surgical critically ill patients: prevalence, incidence, and risk factors. Crit Care Med 33(7):1565–1571CrossRefPubMed
2.
Zurück zum Zitat Ageno W, Becattini C, Brighton T, Selby R, Kamphuisen PW (2008) Cardiovascular risk factors and venous thromboembolism: a meta analysis. Circulation 117(1):93–102CrossRefPubMed Ageno W, Becattini C, Brighton T, Selby R, Kamphuisen PW (2008) Cardiovascular risk factors and venous thromboembolism: a meta analysis. Circulation 117(1):93–102CrossRefPubMed
6.
Zurück zum Zitat Kahn SR, Lim W, Dunn AS et al (2012) Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis, American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest J 141(2 Suppl):e195S–226SCrossRef Kahn SR, Lim W, Dunn AS et al (2012) Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis, American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest J 141(2 Suppl):e195S–226SCrossRef
7.
Zurück zum Zitat Faber DR, de Groot PG, Visseren FLJ (2009) Role of adipose tissue in haemostasis, coagulation and fibrinolysis. Obes Rev 10(5):554–563CrossRefPubMed Faber DR, de Groot PG, Visseren FLJ (2009) Role of adipose tissue in haemostasis, coagulation and fibrinolysis. Obes Rev 10(5):554–563CrossRefPubMed
8.
Zurück zum Zitat Hanley MJ, Abernethy DR, Greenblatt DJ (2010) Effect of obesity on the pharmacokinetics of drugs in humans. Clin Pharmacokinet 49(2):71–87CrossRefPubMed Hanley MJ, Abernethy DR, Greenblatt DJ (2010) Effect of obesity on the pharmacokinetics of drugs in humans. Clin Pharmacokinet 49(2):71–87CrossRefPubMed
9.
Zurück zum Zitat Barletta JF, Deyoung JL, Mcallen K, Baker R, Pendleton K (2008) Limitations of a standardized weight-based nomogram for heparin dosing in patients with morbid obesity. Surg Obes Relat Dis 4(6):748–753CrossRefPubMed Barletta JF, Deyoung JL, Mcallen K, Baker R, Pendleton K (2008) Limitations of a standardized weight-based nomogram for heparin dosing in patients with morbid obesity. Surg Obes Relat Dis 4(6):748–753CrossRefPubMed
10.
Zurück zum Zitat Kim SK, Kim K, Lee S et al (2005) Evaluation of absorption of heparin-DOCA conjugates on the intestinal wall using a surface plasmon resonance. J Pharm Biomed Anal 39(5):861–870CrossRefPubMed Kim SK, Kim K, Lee S et al (2005) Evaluation of absorption of heparin-DOCA conjugates on the intestinal wall using a surface plasmon resonance. J Pharm Biomed Anal 39(5):861–870CrossRefPubMed
11.
Zurück zum Zitat Patel JP, Roberts LN, Arya R (2011) Anticoagulating obese patients in the modern era. Br J Haematol 155:137–149CrossRefPubMed Patel JP, Roberts LN, Arya R (2011) Anticoagulating obese patients in the modern era. Br J Haematol 155:137–149CrossRefPubMed
12.
Zurück zum Zitat Wang TF, Milligan PE, Wong CA, Deal EN, Thoelke MS, Gage BF (2014) Efficacy and safety of high-dose thromboprophylaxis in morbidly obese inpatients. Thromb Haemost 111(1):88–93CrossRefPubMed Wang TF, Milligan PE, Wong CA, Deal EN, Thoelke MS, Gage BF (2014) Efficacy and safety of high-dose thromboprophylaxis in morbidly obese inpatients. Thromb Haemost 111(1):88–93CrossRefPubMed
13.
Zurück zum Zitat Joy M, Tharp E, Hartman H et al (2016) Safety and efficacy of high-dose unfractionated heparin for prevention of venous thromboembolism in overweight and obese patients. Pharmacotherapy 36(7):740–748CrossRefPubMed Joy M, Tharp E, Hartman H et al (2016) Safety and efficacy of high-dose unfractionated heparin for prevention of venous thromboembolism in overweight and obese patients. Pharmacotherapy 36(7):740–748CrossRefPubMed
14.
Zurück zum Zitat Samuel S, Iluonakhamhe EK, Adair E et al (2015) High dose subcutaneous unfractionated heparin for prevention of venous thromboembolism in overweight neurocritical care patients. J Thromb Thrombolysis 40(3):302–307CrossRefPubMed Samuel S, Iluonakhamhe EK, Adair E et al (2015) High dose subcutaneous unfractionated heparin for prevention of venous thromboembolism in overweight neurocritical care patients. J Thromb Thrombolysis 40(3):302–307CrossRefPubMed
15.
Zurück zum Zitat Beall J, Woodruff A, Hempel C, Wovkulich M, Zammit K (2016) Efficacy and safety of high-dose subcutaneous unfractionated heparin prophylaxis for the prevention of venous thromboembolism in obese hospitalized patients. Hosp Pharm 51(5):376–381CrossRefPubMedPubMedCentral Beall J, Woodruff A, Hempel C, Wovkulich M, Zammit K (2016) Efficacy and safety of high-dose subcutaneous unfractionated heparin prophylaxis for the prevention of venous thromboembolism in obese hospitalized patients. Hosp Pharm 51(5):376–381CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Saeed M, Villarroel M, Reisner AT et al (2011) Multiparameter intelligent monitoring in intensive care II: a public-access intensive care unit database. Crit Care Med 39(5):952–960CrossRefPubMedPubMedCentral Saeed M, Villarroel M, Reisner AT et al (2011) Multiparameter intelligent monitoring in intensive care II: a public-access intensive care unit database. Crit Care Med 39(5):952–960CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Goldberger AL, Amaral LAN, Glass L et al (2000) PhysioBank, PhysioToolkit, and PhysioNet. Circulation 101(23):e215–e20CrossRefPubMed Goldberger AL, Amaral LAN, Glass L et al (2000) PhysioBank, PhysioToolkit, and PhysioNet. Circulation 101(23):e215–e20CrossRefPubMed
18.
Zurück zum Zitat Barbar S, Noventa F, Rossetto V, et al (2010) A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score. J Thromb Haemost 8(11):2450–2457CrossRefPubMed Barbar S, Noventa F, Rossetto V, et al (2010) A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score. J Thromb Haemost 8(11):2450–2457CrossRefPubMed
19.
Zurück zum Zitat van Walraven C, Austin PC, Jennings A, Quan H, Forster AJ (2009) A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data. Med Care 47(6):626–633CrossRefPubMed van Walraven C, Austin PC, Jennings A, Quan H, Forster AJ (2009) A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data. Med Care 47(6):626–633CrossRefPubMed
20.
Zurück zum Zitat Tsai AW, Cushman M, Rosamond WD, Heckbert SR, Polak JF, Folsom AR (2002) Cardiovascular risk factors and venous thromboembolism incidence the longitudinal investigation of thromboembolism etiology. Arch Intern Med 162(10):1182–1189CrossRefPubMed Tsai AW, Cushman M, Rosamond WD, Heckbert SR, Polak JF, Folsom AR (2002) Cardiovascular risk factors and venous thromboembolism incidence the longitudinal investigation of thromboembolism etiology. Arch Intern Med 162(10):1182–1189CrossRefPubMed
21.
Zurück zum Zitat WHO (2000) Obesity: preventing and managing the global epidemic. Report of a WHO Consultation. WHO Technical Report Series 894. Geneva: World Health Organization WHO (2000) Obesity: preventing and managing the global epidemic. Report of a WHO Consultation. WHO Technical Report Series 894. Geneva: World Health Organization
22.
Zurück zum Zitat Steinberger J, Jacobs DR, Raatz S, Moran A, Hong CP, Sinaiko AR (2005) Comparison of body fatness measurements by BMI and skinfolds vs dual energy X-ray absorptiometry and their relation to cardiovascular risk factors in adolescents. Int J Obes 29(11):1346–1352CrossRef Steinberger J, Jacobs DR, Raatz S, Moran A, Hong CP, Sinaiko AR (2005) Comparison of body fatness measurements by BMI and skinfolds vs dual energy X-ray absorptiometry and their relation to cardiovascular risk factors in adolescents. Int J Obes 29(11):1346–1352CrossRef
23.
Zurück zum Zitat Willett K, Jiang R, Lenart E, Spiegelman D, Willett W (2006) Comparison of bioelectrical impedance and BMI in predicting obesity-related medical conditions. Obesity (Silver Spring) 14(3):.480–90CrossRef Willett K, Jiang R, Lenart E, Spiegelman D, Willett W (2006) Comparison of bioelectrical impedance and BMI in predicting obesity-related medical conditions. Obesity (Silver Spring) 14(3):.480–90CrossRef
24.
Zurück zum Zitat Sun Q, van Dam RM, Spiegelman D, Heymsfield SB, Willett WC, Hu FB (2010) Comparison of dual-energy X-ray absorptiometric and anthropometric measures of adiposity in relation to adiposity-related biologic factors. Am J Epidemiol 172(12):1442–1454CrossRefPubMedPubMedCentral Sun Q, van Dam RM, Spiegelman D, Heymsfield SB, Willett WC, Hu FB (2010) Comparison of dual-energy X-ray absorptiometric and anthropometric measures of adiposity in relation to adiposity-related biologic factors. Am J Epidemiol 172(12):1442–1454CrossRefPubMedPubMedCentral
Metadaten
Titel
Efficacy of standard dose unfractionated heparin for venous thromboembolism prophylaxis in morbidly obese and non-morbidly obese critically Ill patients
verfasst von
Young R. Lee
Delilah D. Blanco
Publikationsdatum
21.08.2017
Verlag
Springer US
Erschienen in
Journal of Thrombosis and Thrombolysis / Ausgabe 3/2017
Print ISSN: 0929-5305
Elektronische ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-017-1535-8

Weitere Artikel der Ausgabe 3/2017

Journal of Thrombosis and Thrombolysis 3/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.